While mutations in DYNLT3 are not significantly detailed in human disease, reduction of DYNLT3 protein has been observed in late-stage Parkinson’s disease; however, whether or not decreased levels of DYNLT3 protein have a role in Parkinson’s disease or whether they are simply the result of the disease’s progression remains unclear54. This evidence concerns the gene DYNLT3 and Parkinson disease.